Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 32Neoplasms 12Prostatic Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Colonic Neoplasms 9Motor Activity 8Lung Neoplasms 8Endometrial Neoplasms 8Colorectal Neoplasms 8Uterine Cervical Neoplasms 7Rectal Neoplasms 7Obesity 7Tobacco Use Disorder 6Small Cell Lung Carcinoma 6Overweight 6Pancreatic Neoplasms 5Leukemia, Myeloid, Acute 5Breast Carcinoma In Situ 5Urinary Bladder Neoplasms 4Ovarian Neoplasms 4Leukemia 4Head and Neck Neoplasms 4Depression 4Carcinoma, Renal Cell 4Carcinoma, Intraductal, Noninfiltrating 4Stomach Neoplasms 3Sexuality 3Sexual Dysfunction, Physiological 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Oropharyngeal Neoplasms 3

Interventions

Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Castration-Resistant Prostate Cancer (CRPC) × Counseling × Clear all
NCT07240857 2026-05-22

A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer

Zhejiang University

Phase EARLY_PHASE1 Enrolling by invitation
18 enrolled
Genitourinary

Castration-Resistant Prostate Cancer (CRPC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡